{"pageContent": "Background: Tissue preservation strategies have been increasingly used for the management of localized prostate cancer. Focal ablation using ultrasound-guided high-intensity focused ultrasound (HIFU) has demonstrated promising short and medium-term oncological outcomes. Advancements in HIFU therapy such as the introduction of tissue change monitoring (TCM) aim to further improve treatment efficacy.", "metaData": {"source": "Cystic lesions of the prostate gland: an ultrasound classification with pathological correlation\nhttps://pubmed.ncbi.nlm.nih.gov/19091354/"}}